logo
Plus   Neg
Share
Email

Stock Alert: BioNTech Jumps 17% On Positive COVID-19 Vaccine Data

Shares of BioNTech SE (BNTX) are gaining over 17% on Monday morning after a study revealed that the German biotech company and its partner Pfizer's coronavirus vaccine is more that 90% effective.

BNTX is currently trading at $107.64, up $15.64 or 17.00%, on the Nasdaq.

BNT152b2, the Covid-19 vaccine being developed by Pfizer and BioNTech, was found to be more than 90 percent effective in preventing COVID-19 among patients without prior evidence of infection.

The results were based on the first interim efficacy analysis conducted by an external, independent Data Monitoring Committee or DMC from the vaccine's Phase 3 clinical study.

BNT162b2 was found to be effective against COVID-19 in participants without prior evidence of SARS-CoV-2 infection.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
General Electric Co. filed a lawsuit against Siemens Energy AG, accusing the German power distribution company of stealing trade secrets for gas turbines. Siemens Energy allegedly used the information to get at least nine contracts to supply gas turbines to public utilities, and also covered up improper business gains. Following a court ruling, the U.S. Food and Drug Administration postponed the effective date for tobacco manufacturing companies to display new health warnings on cigarette packets and in advertisements, by additional 90 days. The warnings with color images is to promote greater public understanding of the negative health consequences of smoking. JPMorgan Chase & Co (JPM) reported strong results in the fourth quarter of 2020, with net profit up 42% largely driven by credit reserve releases of $2.9 billion. The Group said it ended the year with a CET1 ratio of 13.1% and capital above $200 billion, providing with meaningful capacity to further...
Follow RTT